Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
Journal Information
Full Title: Int J Infect Dis
Abbreviation: Int J Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest The authors have no competing interests to declare."
"Funding Funding was provided by the Program Management Unit for Competitiveness Enhancement, C17F640221 National research, National Higher Education, Science, Research and Innovation Policy Council, Thailand through Clinixir Ltd. The Program Management Unit for Competitiveness Enhancement funded the trial but had no other involvement in the study. Clinixir provided logistical and monitoring supports."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025